08.06.2022 - Globalization has been a key priority for the Company over the past two yearsThree additional market agreements now signed and executed:- Labatec Pharma SA: Switzerland, Middle East & North Africa (MENA) countries- Pharmbio Korea Inc.: South Korea- ... Seite 1